Abstract
RNA interference (RNAi) or Post-Transcriptional Gene Silencing is a strong mechanism of gene silencing which is moderated by MicroRNAs (miRNAs), underlying many fields of eukaryotic biology. The miRNAs are small noncoding RNAs and a gene regulation expression system which showing a tissue-specific expression pattern, and inhibits protein synthesis. For the first time, miRNA has been seen in Caenorhabditis elegans. They play an important role in signaling pathways of various diseases especially periodontal disease during periodontal inflammation and oral cancers. The most important miRNAs in periodontal diseases and oral squamous cell carcinoma are miR-142-3p, miR-146a, miR-155, miR-203, and miR- 223. One of the most important diseases in association with gingival infectious is periodontal diseases which if left untreated, would lead to tooth loss. Hence, the aim of the present study is to focus the effects of miRNAs and their targets in diseases which are mentioned above.
Keywords: MicroRNA, MicroRNA regulation expression, Biomarkers, Periodontal diseases, Porphyromonas gingivalis, Photodynamic therapy.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:Effects of Micro RNAs and their Targets in Periodontal Diseases
Volume: 18 Issue: 3
Author(s): Samane Bourbour, Maryam Beheshti, Hossein Kazemian and Abbas Bahador*
Affiliation:
- Department of Medical Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran,Iran
Keywords: MicroRNA, MicroRNA regulation expression, Biomarkers, Periodontal diseases, Porphyromonas gingivalis, Photodynamic therapy.
Abstract: RNA interference (RNAi) or Post-Transcriptional Gene Silencing is a strong mechanism of gene silencing which is moderated by MicroRNAs (miRNAs), underlying many fields of eukaryotic biology. The miRNAs are small noncoding RNAs and a gene regulation expression system which showing a tissue-specific expression pattern, and inhibits protein synthesis. For the first time, miRNA has been seen in Caenorhabditis elegans. They play an important role in signaling pathways of various diseases especially periodontal disease during periodontal inflammation and oral cancers. The most important miRNAs in periodontal diseases and oral squamous cell carcinoma are miR-142-3p, miR-146a, miR-155, miR-203, and miR- 223. One of the most important diseases in association with gingival infectious is periodontal diseases which if left untreated, would lead to tooth loss. Hence, the aim of the present study is to focus the effects of miRNAs and their targets in diseases which are mentioned above.
Export Options
About this article
Cite this article as:
Bourbour Samane, Beheshti Maryam, Kazemian Hossein and Bahador Abbas*, Effects of Micro RNAs and their Targets in Periodontal Diseases, Infectious Disorders - Drug Targets 2018; 18 (3) . https://dx.doi.org/10.2174/1871526518666180405155327
DOI https://dx.doi.org/10.2174/1871526518666180405155327 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology
Current Medicinal Chemistry Electrical Impedance Scanning - A New Diagnostic Tool in Cancer Detection: Current Status and Recent Developments
Current Medical Imaging Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Current Pharmaceutical Design The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma
Current Gene Therapy Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells
Current Pharmaceutical Biotechnology Pharmacological Modulation of Caspase Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Editorial (Thematic Issue: Proteomic Signatures for Cancer Personalized Medicine)
Current Proteomics New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Role of Erlotinib in Influencing the Quality of Life of Cancer Patients
Clinical Cancer Drugs Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Evolution of Mannose 6-Phosphate Receptors (MPR300 and 46): Lysosomal Enzyme Sorting Proteins
Current Protein & Peptide Science Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology The Use of L-Glucose in Cancer Diagnosis: Results from In Vitro and In Vivo Studies
Current Medicinal Chemistry Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Store-Dependent Ca2+ Entry in Endothelial Progenitor Cells As a Perspective Tool to Enhance Cell-Based Therapy and Adverse Tumour Vascularization
Current Medicinal Chemistry Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Phospho-eIF4E: A New Target for Acute Myeloid Leukemia
Current Protein & Peptide Science Modulation of intracellular pH in human ovarian cancer.
Current Molecular Medicine Effects of Curcumin on Squamous Cell Carcinoma of Tongue: An In Vitro Study
Current Topics in Medicinal Chemistry Molecular and Genetic Bases of Pancreatic Cancer
Current Drug Targets